Scotia Capital’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $13M | Sell |
48,598
-10,270
| -17% | -$2.78M | 0.05% | 183 |
|
|
2025
Q4 | $14.8M | Sell |
58,868
-2,271
| -4% | -$603K | 0.06% | 168 |
|
|
2025
Q3 | $17.6M | Sell |
61,139
-4,889
| -7% | -$1.31M | 0.07% | 148 |
|
|
2025
Q2 | $17.3M | Sell |
66,028
-42,958
| -39% | -$10.5M | 0.08% | 142 |
|
|
2025
Q1 | $25.4M | Buy |
108,986
+5,777
| +6% | +$1.4M | 0.14% | 98 |
|
|
2024
Q4 | $23.7M | Buy |
103,209
+12,832
| +14% | +$2.94M | 0.12% | 101 |
|
|
2024
Q3 | $20.2M | Sell |
90,377
-5,595
| -6% | -$1.23M | 0.11% | 114 |
|
|
2024
Q2 | $19.5M | Buy |
95,972
+5,973
| +7% | +$1.22M | 0.11% | 113 |
|
|
2024
Q1 | $19.7M | Buy |
89,999
+9,871
| +12% | +$2.17M | 0.12% | 110 |
|
|
2023
Q4 | $18.2M | Buy |
80,128
+984
| +1% | +$207K | 0.12% | 105 |
|
|
2023
Q3 | $15.9M | Sell |
79,144
-32,228
| -29% | -$6.8M | 0.12% | 114 |
|
|
2023
Q2 | $19.8M | Buy |
111,372
+9,201
| +9% | +$1.78M | 0.14% | 103 |
|
|
2023
Q1 | $20.1M | Buy |
102,171
+3,103
| +3% | +$639K | 0.15% | 100 |
|
|
2022
Q4 | $20M | Sell |
99,068
-3,341
| -3% | -$653K | 0.15% | 100 |
|
|
2022
Q3 | $18M | Buy |
102,409
+5,459
| +6% | +$1.12M | 0.15% | 101 |
|
|
2022
Q2 | $19.5M | Buy |
96,950
+2,633
| +3% | +$561K | 0.15% | 101 |
|
|
2022
Q1 | $21.4M | Sell |
94,317
-2,364
| -2% | -$556K | 0.14% | 103 |
|
|
2021
Q4 | $26.1M | Buy |
96,681
+3,554
| +4% | +$880K | 0.17% | 91 |
|
|
2021
Q3 | $22.5M | Buy |
93,127
+13,683
| +17% | +$3.45M | 0.16% | 96 |
|
|
2021
Q2 | $18.8M | Buy |
79,444
+3,935
| +5% | +$897K | 0.14% | 106 |
|
|
2021
Q1 | $16.5M | Sell |
75,509
-4,744
| -6% | -$952K | 0.13% | 106 |
|
|
2020
Q4 | $14M | Buy |
80,253
+17,277
| +27% | +$2.98M | 0.13% | 111 |
|
|
2020
Q3 | $10.2M | Buy |
62,976
+7,855
| +14% | +$1.24M | 0.11% | 130 |
|
|
2020
Q2 | $7.87M | Buy |
55,121
+8,058
| +17% | +$1.11M | 0.11% | 122 |
|
|
2020
Q1 | $5.11M | Buy |
47,063
+7,822
| +20% | +$1.13M | 0.07% | 151 |
|
|
2019
Q4 | $5.7M | Sell |
39,241
-4,717
| -11% | -$681K | 0.06% | 164 |
|
|
2019
Q3 | $6.34M | Buy |
43,958
+14,295
| +48% | +$2.09M | 0.07% | 145 |
|
|
2019
Q2 | $4.41M | Sell |
29,663
-12,565
| -30% | -$1.75M | 0.05% | 184 |
|
|
2019
Q1 | $5.55M | Buy |
42,228
+4,375
| +12% | +$539K | 0.07% | 154 |
|
|
2018
Q4 | $4.11M | Buy |
37,853
+10,316
| +37% | +$1.38M | 0.06% | 179 |
|
|
2018
Q3 | $4.11M | Buy |
+27,537
| New | +$4.19M | 0.05% | 199 |
|
Other funds holding LH
VCM
VPM
Scotia Capital's LH Position: Q1 2026 in Review
Scotia Capital reduced its Labcorp (LH) stake by 17% in Q1 2026, selling an estimated $2.78M and leaving 48,598 shares worth $13M. The position accounts for 0.05% of the portfolio, ranked #183.
Scotia Capital first reported a position in LH in Q3 2018 and has held it in 31 quarters since. The position peaked at $26.1M in Q4 2021. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.
- Scotia Capital held 48,598 shares of Labcorp worth $13M as of Q1 2026.
- Scotia Capital sold 10,270 Labcorp shares in Q1 2026, an estimated $2.78M.
- Labcorp made up 0.05% of Scotia Capital's portfolio in Q1 2026, its #183 holding.
- Scotia Capital first reported a position in Labcorp in Q3 2018 and has held it in 31 quarters since.
- Scotia Capital's Labcorp position peaked at $26.1M in Q4 2021.
- 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.
Based on Scotia Capital's 13F filing for Q1 2026, filed 13 May 2026.